ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
Integration of Biomediq Enhances Transpara® Platform for More Precise Risk Stratification and Personalized Breast Cancer Screening
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.
